MedPath

Comparison of Two Types of Braces in the Treatment of Rockwood Type III AC-dislocations

Not Applicable
Completed
Conditions
Acromioclavicular Joint Dislocation
Registration Number
NCT03261778
Lead Sponsor
Bürgerspital Solothurn
Brief Summary

In a randomised prospective comparative Trial the investigators aim to compare the conservative Treatment of acromioclavicular dislocations (Rockwood III) with a conventional sling versus a Acromion 2.0 brace, which exerts a direct Reposition force on the Joint.

The sling/brace will be worn for 6 weeks and the patients will be regularly checked clinically and radiologically.The investigators are interested in differences of shoulder function, Patient satisfaction as well as cosmetic and radiological results.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • First acute acromioclavicular dislocation Rockwood Type III
Exclusion Criteria
  • Previous injury to acromioclavicular Joint
  • Previous surgery of acromioclavicular Joint
  • Known hypersensitivity or allergy to fabric of investigational product
  • Pregnancy
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Shoulder functionat 12 weeks

Subjective Shoulder value (scale 0-100% where 100% equals a healthy shoulder)

Secondary Outcome Measures
NameTimeMethod
Degree of lateral clavicle dislocationat 12 weeks

Coracoclavicular distance on Panorama view in comparison to healthy side

Trial Locations

Locations (2)

Orthopädische Universitätsklinik Basel

🇨🇭

Basel, Switzerland

Bürgerspital Solothurn, Department of Orthopaedics and Traumatology

🇨🇭

Solothurn, Switzerland

Orthopädische Universitätsklinik Basel
🇨🇭Basel, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.